Table 3.
Influenza A viruses identified by LC–MS/MS.
Strains | Subtype | Titera | Sequence coverageb (%) |
Identified asc | ||||
---|---|---|---|---|---|---|---|---|
NP | M1 | NS1 | HA | NA | ||||
BM1454-55 | H3N2 | 109 | 70 | 75 | 56 | 21 | 15 | Influenza A H3N2 |
108 | 49 | 47 | 34 | 17 | 11 | |||
107 | 25 | 18 | 0 | 2 | 0 | |||
106 | 10 | 0 | 0 | 0 | 0 | |||
BM1456-57 | H1N1 | 109 | 72 | 71 | 61 | 18 | 5 | Influenza A H1N1 |
BM1480-85 | 108 | 56 | 49 | 39 | 10 | 4 | ||
107 | 44 | 30 | 15 | 0 | 0 | |||
106 | 14 | 0 | 0 | 0 | 0 |
Tenfold dilution series of each tested influenza strain was prepared and analyzed by LC–MS/MS. Indicated are the total genome copies of the analyzed influenza virus subjected to LC–MS/MS.
Amino acid sequence coverage (%) of proteins determined by MASCOT, as based on identified peptides. Percentages are the averages of combined results for the H3N2 or H1N1 strain. Proteins were considered significantly identified when the MASCOT score was ≥50 and when a minimum of three peptides each with a score of ≥20 was identified. NP, nucleoprotein; M1, matrix protein; NS1, non-structural protein 1; HA, hemagglutinin; NA, neuraminidase;
Identification of type and subtype based on the highest MASCOT scores of nucleoprotein; thus, the given subtypes should be considered as indicative.